Session

IBD II

A MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF A PROBIOTIC PREPARATION AS MAINTENANCE THERAPY IN PATIENTS WITH ULCERATIVE COLITIS.

Yasuo Suzuki, Naoki Yoshimura, Tatsuro Katsuno, Katsuyuki Fukuda

A WATER-SOLUBLE EXTRACT FROM GANODERMA LUCIDUM FUNGUS MYCELIA (DESIGNATED AS MAK) PREVENTS INDOMETHACIN-INDUCED SMALL INTESTINAL INFLAMMATION.

Kenta Nagai, Shinji Tanaka, Shintaro Sagami, Yoshitaka Ueno, Shiro Oka, Shigeto Yoshida, Toru Hiyama, Masanori Ito, Masaharu Yoshihara

ANEMIA IN CROHN’S DISEASE

Chengcheng Ji, Xiang Gao, Min Zhang, Huangwei Chen, Pin Jin Hu

ANORECTAL COMPLICATIONS AND FUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: 14 YEARS FOLLOW-UP

Tze J. Lam, Chris J.J. Mulder, Adriaan van Bodegraven, Richelle Felt-Bersma

ASTHMA PREVALENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Manuel Barreiro de Acosta, Goreti Sánchez-Sindin, Rocío Ferreiro-Iglesias, Nuria García-Couceiro, Aurelio Lorenzo-González, Luis Valdés, Francisco Javier González-Barcala, Juan Enrique Dominguez-Munoz

ATG16L1 GENOTYPE IS ASSOCIATED WITH RESPONSE TO ANTI-TNF

Manon E. Wildenberg, Anne Christine Wilhelmina Vos, Johannan Frank Brandse, Geert R. D'Haens, Gijs R. van den Brink, Alon Levin, Jessica R. de Bruyn, Gijs R. van den Brink

AUTONOMIC NERVOUS SYSTEM FUNCTION PREDICTS THE INFLAMMATORY RESPONSE OVER A THREE-YEAR FOLLOW-UP

Veronica Gunterberg, Lukas Van Oudenhove, Lena Öhman, Magnus Simrén, Hans Strid

AZATHIOPRINE ACHIEVES MUCOSAL HEALING IN PATIENTS WITH EARLY-ONSET CROHN’S DISEASE

Kostas Papamichael, Emmanouil Archavlis, Pantelis Karatzas, Xanthipi Tzanetakou, Iosif Internos, Stylianos Anastasiadis, Nikolaos Kyriakos, Dimitrios Tsironikos, Gerassimos J. Mantzaris

BODY COMPOSITION IN CROHN`S DISEASE PATIENTS BUT NOT IN ULCERATIVE COLITIS PATIENTS IS DIFFERENT COMPARED TO HEALTHY CONTROLS

Chritstoph Dölger, Hermann Schulze, Juliane Thieringer, Jürgen Stein, Axel Dignass

CD80 SIGNALING MANIPULATION AFFECTS TUMOR IMMUNOSURVEILLANCE IN EXPERIMENTAL COLITIS-ASSOCIATED CANCER

Marco Scarpa, Paola BRUN, Ignazio CASTAGLIUOLO, Susan Morgan, Melania Scarpa, Andromachi Kotsafti, Renata D'Incà, Andrea Buda, Carlo Castoro, Giacomo Carlo Sturniolo, Imerio Angriman

CIRCULATING B CELL SUBSETS CORRELATE WITH CLINICAL RESPONSE TO ANTI-TNF THERAPY IN IBD

Zhe Li, Severine Vermeire, Dominique Bullens, Marc Ferrante, Kristel Van Steen, Maja Noman, Paul Rutgeerts, Jan L. Ceuppens, Gert Van Assche

CLINICAL PHARMACOLOGY AND SAFETY OF AMG 181, A HUMAN ANTI-Α4Β7 ANTIBODY FOR TREATING INFLAMMATORY BOWEL DISEASES

Wei-Jian Pan, Barbara Sullivan, William Rees, Christine Evangelista, David Doherty, Peter Prince, Kai Reynhardt, Kefei Zhou, David Han, Jonathan Lee, Zhigang Yu, Dominic Borie

CLINICAL PHARMACOLOGY, SAFETY, AND EFFECTS OF ANTI-IL-23 ANTIBODY AMG 139

Wei-Jian Pan, William Rees, Jennifer Towne, John Gibbs, Alexander Colbert, Theresa Goletz, Kathryn Newhall, Kefei Zhou, Samantha Prokop, Amber Umble-Romero, Christina Krill, Ping-Cheng Yi, Nathan Standifer, Jonathan Lee, George Hodsman, Jason Lickliter, John Wishart, Sepehr Shakib, Catherine Reid, Joanne Marjason, Chris

CONTRIBUTION OF MDR1 GENE POLYMORPHISMS ON IBD PREDISPOSITION AND RESPONSE TO GLUCOCORTICOIDS IN IBD IN CHINESE POPULATION

Qingfan Yang, Baili CHEN, Qingsen Zhang, Yao HE, Minhu Chen, Zhirong Zeng

CORRELATION BETWEEN THE CROHN’S DISEASE ACTIVITY INDEX AND A WEB-BASED SELF-REPORTING SYMPTOMS DIARY OF CROHN’S DISEASE

Eun-Soo Kim, Kwang-Bum Cho, Kyung Sik Park, Kyeong-Ok Kim, Seong Woo Jeon, Min Kyu Jung, Eun Young Kim, Chang Heon Yang, Byung Ik Jang, Seong Woo Jeon

CROHN’S DISEASE-ASSOCIATED ADHERENT-INVASIVE ESCHERICHIA COLI MANIPULATE HOST AUTOPHAGY BY IMPAIRING SUMOYLATION

Guillaume Dalmasso, Hang Thi Thu Nguyen, Laetitia Goulème, Antony Cougnoux, Lucie Gibold, Richard Bonnet

DAIKENCHUTO (TU-100) RAISES PLASMA LEVELS OF ADRENOMEDULLIN IN PATIENTS WITH CROHN’S DISEASE: POSSIBLE MECHANISM OF CLINICAL ACTION

Hiroshi Yamasaki, Keiichi Mitsuyama, Teppei Kobayashi, Kotaro Kuwaki, Shinichiro　 Yoshioka, Koji Nagayama, Hidetoshi Takedatsu, Michio Sata

DETERMINATION OF IMMUNE SURVEILLANCE IN CEREBROSPINAL FLUID (CSF) IN PATIENTS WITH CROHN’S DISEASE: INITIAL RESULTS OF THE TOSCA STUDY

André Van Gossum, Richard Ransohoff, Olaf Stuve, John Cheng, Yanhua Zhang, Sunday Rivers, Gail M. Comer, Bo Jin, Kenneth Gorelick, Mina Hassan-Zahraee, Fabio Cataldi, Walter Reinisch, Geert R. D'Haens

DEVELOPMENT OF A NOVEL INDEX OF CT ENTEROGRAPHY FOR EVALUATING SEVERITY OF CROHN'S DISEASE

Sayuri Sazuka, Tatsuro Katsuno, Masaya Saito, Tomoo Nakagawa, Shoko Minemura, Kenichirou Okimoto, Daisuke Maruoka, Tomoaki Matsumura, Makoto Arai, Osamu Yokosuka

DEVELOPMENT OF THE ULCERATIVE COLITIS PATIENT-REPORTED OUTCOMES (UC-PRO) QUESTIONNAIRE

Gale Harding, Donald Patrick, Dennis Revicki, Sarah Trease, Gary Globe, Hema Viswanathan, Kristina Fitzgerald, Dominic Borie, Brian G. Ortmeier, Nancy Kline Leidy, Peter D.R. Higgins

DIFFERENT INFLAMMASOME TYPES COLLABORATE IN HUMAN INFLAMMATORY BOWEL DISEASES

Dominiek Staelens, Paul Peeters, Jan van der Goten, Emiel F.M. Wouters, Gert Van Assche, Marc Ferrante, Severine Vermeire, Paul Rutgeerts, Kris Nys, Ingrid Arijs

DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING IN CROHN'S DISEASE: VALIDATION OF QUANTITATIVE INDEX OF ACTIVITY

Anthony Buisson, Julien Scanzi, Félix Goutorbe, Bruno Simões Pereira, Corinne Borderon, Gilles Bommelaer, Virginie Petitcolin

DIFFUSION WEIGHTED MRI OF INFLAMMATORY BOWEL DISEASE

Sarah Aurakzai, Sofia Gourtsoyianni, Simon H. Anderson, Peter Irving, Vicky Goh, Nyree Griffin, Jeremy Sanderson

DISTINCT CELL SIGNALLING MECHANISMS DRIVE THE TUMOUR NECROSIS FACTOR ALPHA AND INTERFERON GAMMA-INDUCED TRANSCRIPTIONAL DOWNREGULATION OF AQUAPORIN 3 RNA EXPRESSION

Michael Augustyn Peplowski, Andrew Joseph Vegso, Wallace Keith MacNaughton

DISTRIBUTION OF DIAGNOSTIC CRITERIA FOR COLLAGENOUS COLITIS – POOLED ANALYSIS OF 2 EUROPEAN CLINICAL TRIALS

Stephan Miehlke, Daniela Aust, Ole Kristian Bonderup, Johan Bohr, Ahmed Madisch, Michael Vieth, Henrik Hjortswang, Fernando Fernández-Bañares, Curt Tysk, Magnus Strom, Ralph Mueller, Roland Greinwald, Andreas Münch, Ralf Mohrbacher

EARLY DISEASE COURSE IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM AN INCEPTION COHORT STUDY IN ASIA-PACIFIC

Siew Chien Ng, Corrie Studd, Kaichun Wu, Yufang Wang, Khean-Lee Goh, Khoon Lin Ling, Choon Jin Ooi, Lawrence K Ho, Eng Hui David Ong, Pises Pisespongsa, Sathaporn Manatsathit, Satimai Aniwan, Murdani Abdullah, Tai-chiu Wong, Steve Tsang, W S Yasith Udara, Joseph Jao Yiu Sung, Francis Ka Leung Chan, Michael A. Kamm, Khean

EARLY POST-OPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE PATIENTS: DATA FROM AN ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD) STUDY ON A LARGE PROSPECTIVE MULTICENTER COHORT

Ambrogio Orlando, Filippo Mocciaro, Sara Renna, Daniela Scimeca, Antonio Rispo, Maria Lia Scribano, Anna Testa, Annalisa Aratari, Fabrizio Bossa, Rosy Tambasco, Erika Angelucci, Sara Onali, Maria Cappello, Walter Fries, Renata D'Incà, Matteo Martinato, Claudio Papi, Vito Annese, Paolo Gionchetti, Fernando Rizzello, Pier

EFFECT OF A PROBIOTIC PREPARATION(VSL#3) IN THE PATIENTS WITH ULCERATIVE COLITIS: ITS EFFECT ON CYTOKINES

Ji Hyun Lee, Hyeok Jin Kwon, Woo Jin Jung, Pyoung Ju Seo

EFFECTS OF ANTI-TNF THERAPY IN THE MONITORING OF HISTOLOGICAL ACTIVITY IN PATIENTS WITH CROHN'S DISEASE

Lourdes Lol-Be Pinzon, Tomas Cortes Espinosa, Moises Salamanca

EFFECTS OF PHYSICAL EXERCISE ON BONE MINERAL DENSITY IN PATIENTS WITH ULCERATIVE COLITIS

Marco Sanges, Davide Trio, Martina Miniero, Orsola Donatore, Rosa Sollazzo, Daniele Mattera, Agesilao D'Arienzo

EFFICACY AND SAFETY OF ADALIMUMAB IN MODERATE TO SEVERE PAEDIATRIC CROHN’S DISEASE: SINGLE TERTIARY CENTRE OUTCOME

Aspasia Angelakopoulou, Daniel Curwen, Keith Lindley, Neil Shah, Mamoun Elawad, Fevronia Kiparissi

EFFICACY AND SAFETY OF INFLIXIMAB SALVAGE THERAPY FOR PATIENTS WITH ULCERATIVE COLITIS WHO FAILED TO TACROLIMUS

Hironobu Tsukamoto, Satoshi Tanida, Tsutomu Mizoshita, Keiji Ozeki

EFFICACY OF ADALIMUMAB IN CHILDREN AND ADOLESCENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Eleni Volonaki, Neil Shah, Keith Lindley, Fevronia Kiparissi, Mamoun Elawad

EFFICACY OF INFLIXIMAB IN PAEDIATRIC ULCERATIVE COLITIS: SINGLE TERTIARY CENTRE EXPERIENCE

Eleni Volonaki, Keith Lindley, Neil Shah, Fevronia Kiparissi, Mamoun Elawad

EFFICACY OF PROBIOTIC TREATMENT WITH BIFIDOBACTERIUM LONGUM 536 FOR INDUCTION OF REMISSION IN ACTIVE ULCERATIVE COLITIS: A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED MULTICENTER TRIAL

Hiroyuki Tamaki, Hiroshi Nakase, Kazuyoshi Namba, Tsutomu Chiba

ELEVATED MATRIX METALLOPROTEINASE-3 LEVELS IN SERUM CORRELATED WITH CROHN’S DISEASE SEVERITY: EFFICACY AS CLINICAL BIOMARKER

Kousaku Kawashima, Shunji Ishihara, Hiroki Sonoyama, Yasumasa Tada, Akihiko Oka, Ryusaku Kusunoki, Nobuhiko Fukuba, Naoki Oshima, Ichiro Moriyama, Takafumi Yuki, Yoshikazu Kinoshita

ENTERO-URINARY FISTULAS TREATED WITH ANTI-TNF: OUTCOMES AND PREDICTORS OF RESPONSE

Carlos Taxonera Samso, Manuel Barreiro de Acosta, Javier Martinez Gonzalez, Olga Merino, Valle García-Sánchez, Ignacio Marín-Jiménez, Maria Chaparro Sanchez, Jose Fernando Muñoz Nuñez, Fernando Bermejo, Leticia Pérez Carazo, Rocio Plaza, Juan L Mendoza, Javier Gisbert

EPIGENETIC ALTERATIONS IN INFLAMMATORY BOWEL DISEASE: NEW INSIGHTS INTO DISEASE PATHOGENESIS

Alfa Hsing Chen Bai, Massimo Catarinella, Marcus Harbord, Jung-Hwan Yu, Siew Chien Ng, Alfred Sze Lok Cheng

HLA-DRB1 AND THE DEVELOPMENT OF ANTIBODIES TO INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE

Thomas Billiet, Niels Vande Casteele, Isabelle Cleynen, Vera Ballet, Ann Gils, Marc Ferrante, Paul Rutgeerts, Severine Vermeire

HYPOXIS HEMEROCALLIDEA CORM AMELIORATES ACUTE EXPERIMENTAL COLITIS

Isabel Villegas, Denitsa Todorova-Aleksieva, Susana Sanchez-Fidalgo, Marina Aparicio Soto, Ana Cardeno, Marta Uceda-Martin, Catalina Alarcon de la Lastra

IDENTIFICATION OF DISEASE-ASSOCIATED DNA METHYLATION IN BLOOD FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Pantelis Karatzas, Maria Gazouli, Michail Safioleas, Gerassimos J. Mantzaris

IMMUNOSUPPRESSANT EFFECT OF MESENCHYMAL STROMAL CELLS ON MUCOSAL T CELLS FROM CROHN’S DISEASE PATIENTS

Rachele Ciccocioppo, Alessandra Gallia, Venerina Imbesi, Giusy Cristina Cangemi, Elena Betti, Giulio Petazzi, Laura Vanelli, Cristina Picone, Patrizia Comoli, Antonella Gurrado, Lodovica Pozzi, Maria Ester Bernardo, Franco Locatelli, Gino Roberto Corazza

IMPACT OF CYTOMEGALOVIRUS AND ITS TREATMENT ON INFLAMMATORY BOWEL DISEASE FLARE-UPS

Maxime Delvincourt, Anthony Lopez, Sylvie Pillet, Anne Bourrier, Philippe Seksik, Jacques Cosnes, Fabrice Carrat, Joel Gozlan, Laurent Beaugerie, Xavier Roblin, Laurent Peyrin-Biroulet, Harry Sokol

INFLAMMATION DRIVEN FIBROSIS IN ULCERATIVE COLITIS – INVESTIGATION OF A NEGLECTED PROBLEM

Jessica R. de Bruyn, Sybren L. Meijer, Manon E. Wildenberg, Gijs R. van den Brink, Geert R. D'Haens

INFLIXIMAB (IFX) DOES NOT INCREASE THE RISK OF CYTOMEGALOVIRUS (CMV) INFECTION AND CMV IS NOT ASSOCIATED TO RESISTANCE TO IFX THERAPY

Sylvie Pillet, Emile Del Tedesco, mathilde courault, emilie presles, amelie moreau, Bruno Pozzetto, Xavier Roblin

INFLIXIMAB IS EFFECTIVE AT PREVENTING RESTENOSIS AFTER THE ENDOSCOPIC BALLOON DILATATION THERAPY IN PATIENT'S WITH CROHN'S DISEASE.

Masayuki Saruta, Seiji Arihiro, Daisuke Ide, Tetsuyoshi Iwasaki, Nobuhiko Komoike, Yoshinori Arai, Hisao Tajiri, Tomohiro Kato

INFLUENCE OF EXTRAINTESTINAL MANIFESTATIONS IN HEALTH-RELATED QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS

Manuel Barreiro de Acosta, Marta iglesias-rey, Juan Enrique Dominguez-Munoz

INFLUENCE OF MELATONIN ON THE COURSE OF ULCERATIVE COLITIS

Oga Alexandrovna Rassokhina, Andrey Dorofeyev, Inna Vasilenko

INFLUENCE OF STRESS IN THE CLINICAL COURSE OF INFLAMMATORY BOWEL DISEASE PATIENTS

Manuel Barreiro de Acosta, Marta iglesias-rey, Rocío Ferreiro-Iglesias, Aurelio Lorenzo-González, Juan Enrique Dominguez-Munoz

INHIBITION OF EOTAXIN-1 (CCL-11) AMELIORATES DSS-INDUCED COLITIS – A NOVEL POTENTIAL THERAPEUTIC APPROACH FOR INFLAMMATORY BOWEL DISEASE

Tomer Adar, Shimon Shteingart, Dan Meir Livovsky, Ariella Bar Gil Shitrit, Mahmud Mahamid, Eran Goldin, Benjamin Koslowsky

Item 1 - 50 / 100
1
2